Salud Ciencia y Tecnología,
Journal Year:
2023,
Volume and Issue:
3, P. 883 - 883
Published: Dec. 31, 2023
Introduction:
the
gut
microbiota
is
a
potential
determining
factor
in
development
of
obesity,
resulting
dysbiosis,
which
related
to
lower
number
members
Bacteroidetes
division
and
an
increase
Firmicutes
leading
decrease
energy
expenditure,
it
also
associated
with
inflammatory
process,
insulin
resistance
type
2
diabetes
mellitus.
Objective:
carry
out
literature
review
effects
probiotics
on
improvement
intestinal
obese
patient
its
disorders.Methods:
search
articles
PubMed,
Google
Scholar
Elsevier
from
last
five
years
was
carried
using
terms
"obesity
probiotics",
"effect
"gut
probiotics".
A
total
23
were
included
selection
criteria.
Results:
supplementation
specifically
certain
strains
such
as
Lactobacillus
plantarum
Bifidobacterium
could
lead
significant
weight
reductions,
combination
restriction
physical
activity.
However,
important
develop
clinical
trials
that
are
properly
designed,
including
all
aspects
lifestyle,
microbiota,
metabolites,
genetic
background.Conclusions:
despite
beneficial
effects,
they
not
yet
considered
alternative
strategy
treatment
obesity
due
lack
research
this
field,
since
currently
available
data
come
studies
animals
may
present
humans.
It
conduct
more
large-scale
longitudinal
longer
follow-up
Life Sciences,
Journal Year:
2024,
Volume and Issue:
354, P. 122948 - 122948
Published: Aug. 6, 2024
The
gut-liver
axis
plays
a
pivotal
role
in
maintaining
body
homeostasis.
Disruption
of
the
is
linked
to
multitude
diseases,
including
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD).
Probiotic
strains
from
Lactobacillaceae
family
are
commonly
used
mitigate
experimental
MASLD.
Over
years,
numerous
studies
have
demonstrated
efficacy
these
probiotics,
often
focusing
on
outcome
disease.
This
review
aims
further
understand
MASLD
as
systemic
dysfunction
and
highlight
effects
probiotics
multi-organ
axis,
organs
such
gastrointestinal
tract,
pancreas,
muscle,
adipose
tissue,
immune
system.
We
specifically
discuss
evidence
how
supplementation
with
may
alleviate
by
not
only
restoring
health
but
also
modulating
physiology
other
organ
systems.
Metabolites,
Journal Year:
2024,
Volume and Issue:
14(12), P. 704 - 704
Published: Dec. 13, 2024
Background/Objectives:
Dietary
patterns,
including
high-fat
and
high-carbohydrate
diets
(HFDs
HCDs),
as
well
non-dietary
factors
such
food
additives
antibiotics,
are
strongly
linked
to
metabolic
endotoxemia,
a
critical
driver
of
low-grade
chronic
inflammation.
This
review
explores
the
mechanisms
through
which
these
impair
intestinal
permeability,
disrupt
gut
microbial
balance,
facilitate
lipopolysaccharide
(LPS)
translocation
into
bloodstream,
contributing
disorders
obesity,
type
2
diabetes
mellitus,
inflammatory
bowel
disease.
Methods:
The
analysis
integrates
findings
from
recent
studies
on
effects
dietary
components
microbiota
interactions
barrier
function
systemic
Focus
is
given
experimental
designs
assessing
permeability
using
biochemical
histological
methods,
alongside
profiling
in
both
human
animal
models.
Results:
HFDs
HCDs
were
shown
increase
LPS
levels,
inducing
dysbiosis
compromising
integrity.
resulting
endotoxemia
promoted
state
inflammation,
disrupting
regulation
pathogenesis
various
diseases.
Food
antibiotics
further
exacerbated
by
altering
composition
increasing
permeability.
Conclusions:
Diet-induced
alterations
dysfunction
emerge
key
mediators
related
disorders.
Addressing
patterns
their
impact
health
crucial
for
developing
targeted
interventions.
Further
research
warranted
standardize
methodologies
elucidate
translating
clinical
applications.
Research Journal of Pharmacy and Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 94 - 102
Published: Jan. 27, 2025
Probiotics
have
been
widely
used
to
treat
lipid
metabolism
disorders
associated
with
obesity
by
modifying
the
microbiota
balance.
play
a
role
in
health
maintaining
intestinal
homeostasis,
alienating
pathogens,
increasing
nutrient
bioavailability,
and
stimulating
modulating
immune
system.
Various
local
probiotics
also
developed
as
source
of
assist
issues.
One
is
probiotic
Lactoplantibacilus
pentosus,
which
comes
from
dadih
(traditional
fermented
buffalo
milk
West
Sumatera
).
This
research
aimed
assess
impact
pentosus
on
oxidative
stress,
adipose
tissue,
liver
histopathology
mice
fed
high-fat
diet
(HFD).
Methods:
The
experimental
setup
involved
dividing
into
four
groups,
each
consisting
seven
animals.
These
groups
were
randomly
assigned
one
dietary
regimens:
ND
(Normal
Diet),
HFD
(High
Fat
HFDL
Diet
supplemented
L.
at
109
CFU/ml),
HDLFL
containing
CFU/ml).
In
was
delivered
orally
once
day
for
six
weeks
1
x
CFU/mL
dosage.
Result:
Following
6-week
diet,
group
had
24.30%
higher
body
weight
than
group.
exhibited
lower
(23.78±0.84g)
compared
(26.59
±
1.17g),
statistically
significant
difference
(p<0.05).
Animals
given
antioxidant
SOD
levels
MDA
Adipocyte
hypertrophy,
observed
animals
mitigated
administration
Lactobacillus
pentosus.
steatosis,
inflammation,
fibrosis,
necrosis
normal
Steatosis,
necrosis,
fibrotic
scores
decreased
Lactiplantibacillus
milk.
Conclusion:
derived
has
shown
reduce
obesity,
hepatic
stress
people
who
regularly
consume
diets.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: March 26, 2025
Introduction
Obesity
is
a
complex
metabolic
disease,
which
often
accompanied
with
impaired
glucose
and
lipid
metabolism
chronic
inflammation.
Probiotics
have
been
considered
as
strategy
for
treating
obesity,
while
the
genus
of
Lactobacillus
most
commonly
tested
approved
probiotics.
Some
multi-strain
probiotics
were
proven
to
produce
synergistic
effects
on
obesity
compared
mono-strain
ones.
Methods
The
purpose
this
study
was
investigate
anti-obesity
effect
new
probiotic
formation
contained
plantarum
L14,
paracasei
L9,
rhamnosus
GG,
sakei
X-MRS-2,
designated
L-PPRS.
Multi-strain
L-PPRS
shown
better
antiadipogenic
than
in
3T3-L1
cell.
Subsequently,
orally
supplemented
high-fat
diet
(HFD)
induced
obese
mouse
model
two
kinds
treatment
course,
short-term
(8
weeks)
one
long-term
(12
one.
Results
We
found
that
intervention
not
only
significantly
inhibited
weight
gain
HFD-fed
mice,
but
also
improved
tolerance,
insulin
sensitivity
reduced
serum
levels.
Furthermore,
fat
accumulation
adipose
tissue
liver,
ameliorated
antioxidant
capacity
liver
mice.
modulated
expression
lipid-metabolic
genes,
exhibited
excellent
anti-inflammatory
effect.
In
addition,
restored
dysbiosis
gut
microbiota
via
reducing
Firmicutes/
Bacteroidetes
ratio,
increasing
abundance
beneficial
intestinal
bacteria.
conclusion,
proved
could
effectively
prevent
development
its
associated
abnormalities,
supplementation
provided
more
profound
benefit
short-term.
Discussion
This
highlights
potential
an
effective
strategy.
Saudi Journal of Biological Sciences,
Journal Year:
2023,
Volume and Issue:
30(10), P. 103790 - 103790
Published: Aug. 23, 2023
Obesity
is
a
polygenic
disorder
which
has
become
global
epidemic
in
recent
years.
Aim
of
the
present
study
was
to
assess
theranostic
potential
probiotics
(Lactobacillus
bulgaricus,
Bifidobacterium)
and
local
herbs
(fenugreek
seeds,
aloe
vera)
on
body
weight,
biochemical
(liver
kidney
functions)
histology
some
internal
organs
(liver,
kidney,
ovary,
small
intestine)
obese
rats.
In
study,
nanoemulsions
were
formulated
by
high
energy
method
characterized
FTIR
UV
analysis.
One
hundred
sixty
(1
6
0)
female
wistar
rats
divided
into
sixteen
groups.
A
high-fat
diet
given
induce
obesity
them.
Obese
treated
with
different
doses
probiotics,
their
combination.
Weekly
weight
monitored.
Rats
dissected
after
fifteen
weeks;
blood
harvested
for
analysis
histology.
Results
demonstrated
protective
effect
nanoemulsion
central
vein,
glomerulus,
villi
normal
ovulatory
function
combination
exhibited
improved
levels
bilirubin
(4
mg/dl
to15
mg/dl),
AST
from
(110
U/L
18
U/L)
ALT
(52
10U/L).
Similar
renoprotective
effects
recorded
overall
renal
tests
(RFT).
post
treatment
urea
(63
22
mg/dl)
creatinine
(0.2
0.8
levels.
It
therefore
evident
that
reverse
parameters
histological
architecture
liver,
intestine
ovary.
The
results
indicated
have
positive
own,
but
when
combined
herbs,
they
produced
highly
effective
can
be
used
as
complementary
option
individuals.
Salud Ciencia y Tecnología - Serie de Conferencias,
Journal Year:
2023,
Volume and Issue:
2, P. 549 - 549
Published: Dec. 20, 2023
Introduction:
the
gut
microbiota
is
a
potential
determining
factor
in
development
of
obesity,
resulting
dysbiosis,
which
related
to
lower
number
members
Bacteroidetes
division
and
an
increase
Firmicutes
leading
decrease
energy
expenditure,
it
also
associated
with
inflammatory
process,
insulin
resistance
type
2
diabetes
mellitus.
Objective:
conduct
literature
review
effects
probiotics
on
improvement
intestinal
obese
patient
its
disorders.
Methods:
search
articles
PubMed,
Google
Scholar
Elsevier
from
last
five
years
was
conducted
using
terms
"obesity
probiotics",
"effect
"gut
probiotics".
A
total
23
were
included
selection
criteria.
Results:
supplementation
specifically
certain
strains
such
as
Lactobacillus
plantarum
Bifidobacterium
could
lead
significant
weight
reductions,
combination
restriction
physical
activity.
However,
important
develop
clinical
trials
that
are
properly
designed,
including
all
aspects
lifestyle,
microbiota,
metabolites,
genetic
background.
Conclusions:
despite
beneficial
effects,
they
not
yet
considered
alternative
strategy
treatment
obesity
due
lack
research
this
field,
since
currently
available
data
come
studies
animals
may
present
humans.
It
more
large-scale
longitudinal
longer
follow-up.